Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 30, 2016

 

Exhibit 21.1

 

Subsidiaries of the Registrant

 

EyeGate Pharma S.A.S. (France)
Jade Therapeutics, Inc. (United States)